FDA Inspection 1015301 — Adiv Goldhaber
The FDA completed an inspection of Adiv Goldhaber on May 24, 2017 in Ra'anana. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- May 24, 2017
- Fiscal Year
- 2017
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Ra'anana (Israel)
Additional Details
Clinical Investigator (CI)